1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid has been researched along with 2',6'-dimethyltyrosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, W; Butterworth, J; Labarre, M; McClory, A; Mischki, T; Pagé, D; Payza, K; Schmidt, R; St-Onge, S | 1 |
| Bellemare, D; Brown, W; Coupal, M; Gosselin, M; Labarre, M; Naismith, A; Pagé, D; Payza, K; Schmidt, R | 1 |
2 other study(ies) available for 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid and 2',6'-dimethyltyrosine
| Article | Year |
|---|---|
Novel Dmt-Tic dipeptide analogues as selective delta-opioid receptor antagonists.
Topics: Benzamides; Binding, Competitive; Dipeptides; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Isoquinolines; Piperazines; Receptors, Opioid, delta; Tetrahydroisoquinolines; Tyrosine | 2000 |
Novel C-terminus modifications of the Dmt-Tic motif: a new class of dipeptide analogues showing altered pharmacological profiles toward the opioid receptors.
Topics: Dipeptides; Humans; Isoquinolines; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Tetrahydroisoquinolines; Tyrosine | 2001 |